|1.||Sharma, Kiran: 1 article (01/2015)|
|2.||Zafar, Rasheeduz: 1 article (01/2015)|
|3.||Chand, Pradeep K: 1 article (10/2012)|
|4.||Rout, Kedar K: 1 article (10/2012)|
|5.||Swain, Swasti S: 1 article (10/2012)|
|6.||Mukherjee, Pulok K: 1 article (09/2012)|
|7.||Nema, Neelesh K: 1 article (09/2012)|
|8.||Sarkar, Birendra K: 1 article (09/2012)|
|9.||Maity, Niladri: 1 article (09/2012)|
|10.||Sharma, M K: 1 article (05/2002)|
10/01/2012 - "To date, this is the first report claiming production of the cancer therapeutic phytochemical taraxerol in genetically transformed root cultures as a viable alternative to in vivo roots of naturally occurring plant species."
10/01/2012 - "Production of triterpenoid anti-cancer compound taraxerol in Agrobacterium-transformed root cultures of butterfly pea (Clitoria ternatea L.)."
01/01/2015 - "This review throws light on two natural triterpenes - Taraxerol and Taraxasterol which have many important pharmacological actions including anti-cancer activity, their chemistry, biosynthesis aspects, and possible use of these compounds as drugs in treatment of cancer. "
06/01/1999 - "Of these triterpenoids, taraxasterol (1) and taraxerol (7) exhibited significant inhibitory effects on EBV-EA induction, but the inhibitory effects of their acetates 2 and 8 were weaker than those of 1 and 7. Furthermore, 1 and 7 exhibited potent anti-tumor-promoting activity in the two-stage carcinogenesis tests of mouse skin using 7,12-dimethylbenz[a]anthracene (DMBA) as an initiator and TPA as a promoter, and 1 showed a remarkable inhibitory effect on mouse spontaneous mammary tumors using C3H/OuJ mouse. "
|2.||Wounds and Injuries (Trauma)
|5.||Acetates (Acetic Acid Esters)
|7.||Epstein-Barr virus early antigen